ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Live Donor Liver Transplantation with Older Donors Only Impacts on a Late HCV Recurrence.

N. Goldaracena, G. Sapisochin, A. Barbas, M. Dib, D. Al-Adra, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, M. Selzner.

Abdominal Organ Transplant, Toronto General Hospital, Toronto, ON, Canada.

Meeting: 2016 American Transplant Congress

Abstract number: A201

Keywords: Living-related liver donors

Session Information

Session Name: Poster Session A: Living Donor Liver Transplantation

Session Type: Poster Session

Date: Saturday, June 11, 2016

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Introduction:Impact of donor age on HCV recurrence in live donor liver transplant (LDLT) recipients is controversial. We compared HCV progression in recipients receiving a graft from a live donors ≥50 vs < 50 years.

Methods: From 2000-2014, 159 patients with HCV received a LDLT at our institution. Outcomes of patients receiving a graft from donors ≥50 years (LDLT≥50=31) vs <50 years (LDLT<50=128) were compared.

Results: No difference was observed between groups regarding recipient demographics and disease severity. Recipient ICU (LDLT<50:2 vs. LDLT≥50:2 days; p=0.88) and hospital stay (LDLT<50:13 vs. LDLT≥50:16 days; p=0.41) after transplantation was similar. Major complications (Clavien ≥3b) were similar between both groups (LDLT<50:22% vs. LDLT≥50:25%; p=0.63). Rejection episodes did not differ among groups (LDLT<50:25% vs. LDLT≥50:16%; p=0.35). Overall HCV recurrence was similar between both groups (LDLT<50: 56% vs. LDLT≥50: 71%; p=0.15). HCV 1-year recurrence with a METAVIR score ≥2 was also similar (LDLT<50: 10% vs. LDLT≥50: 16%; p=0.35). Although 1-(89%vs.87%), 5-(77%vs.70%) and 10-(71%vs.55%) year graft survival was similar between groups (p=0.096), HCV recurrence was the main reason for graft failure in both groups and significantly higher in the LDLT≥50 group (LDLT<50: 21% vs. LDLT≥50: 62%; p=0.002). Late HCV recurrence only manifested itself after 5 years and did not impact on patient survival at 1-(90%vs.90%), 5-(78%vs.69%) and 10-(71%vs.60%) (p=0.25).

Conclusion: LDLT with older donors (≥50) for HCV patients resulted in an increased late HCV recurrence. Graft and patient survival remained to be similar when receiving grafts from older vs. younger donors.

CITATION INFORMATION: Goldaracena N, Sapisochin G, Barbas A, Dib M, Al-Adra D, Selzner N, Cattral M, Greig P, Lilly L, McGilvray I, Levy G, Ghanekar A, Renner E, Grant D, Selzner M. Live Donor Liver Transplantation with Older Donors Only Impacts on a Late HCV Recurrence. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Goldaracena N, Sapisochin G, Barbas A, Dib M, Al-Adra D, Selzner N, Cattral M, Greig P, Lilly L, McGilvray I, Levy G, Ghanekar A, Renner E, Grant D, Selzner M. Live Donor Liver Transplantation with Older Donors Only Impacts on a Late HCV Recurrence. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/live-donor-liver-transplantation-with-older-donors-only-impacts-on-a-late-hcv-recurrence/. Accessed May 31, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences